BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24892190)

  • 1. Homing peptide-conjugated gold nanorods: the effect of amino acid sequence display on nanorod uptake and cellular proliferation.
    Alkilany AM; Boulos SP; Lohse SE; Thompson LB; Murphy CJ
    Bioconjug Chem; 2014 Jun; 25(6):1162-71. PubMed ID: 24892190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual targeting for metastatic breast cancer and tumor neovasculature by EphA2-mediated nanocarriers.
    Guo Z; He B; Yuan L; Dai W; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
    Int J Pharm; 2015 Sep; 493(1-2):380-9. PubMed ID: 26004003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmon-activated nanozymes with enhanced catalytic activity by near-infrared light irradiation.
    Liu X; Wan Y; Jiang T; Zhang Y; Huang P; Tang L
    Chem Commun (Camb); 2020 Feb; 56(12):1784-1787. PubMed ID: 31950129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication of doxorubicin functionalized gold nanorod probes for combined cancer imaging and drug delivery.
    Wang T; Zhang X; Pan Y; Miao X; Su Z; Wang C; Li X
    Dalton Trans; 2011 Oct; 40(38):9789-94. PubMed ID: 21879078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narrow band imaging of squamous cell carcinoma tumors using topically delivered anti-EGFR antibody conjugated gold nanorods.
    Puvanakrishnan P; Diagaradjane P; Kazmi SM; Dunn AK; Krishnan S; Tunnell JW
    Lasers Surg Med; 2012 Apr; 44(4):310-7. PubMed ID: 22415634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells.
    Manju S; Sreenivasan K
    J Colloid Interface Sci; 2012 Feb; 368(1):144-51. PubMed ID: 22200330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming the Heat Endurance of Tumor Cells by Interfering with the Anaerobic Glycolysis Metabolism for Improved Photothermal Therapy.
    Chen WH; Luo GF; Lei Q; Hong S; Qiu WX; Liu LH; Cheng SX; Zhang XZ
    ACS Nano; 2017 Feb; 11(2):1419-1431. PubMed ID: 28107631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling.
    Gomez-Soler M; Petersen Gehring M; Lechtenberg BC; Zapata-Mercado E; Hristova K; Pasquale EB
    J Biol Chem; 2019 May; 294(22):8791-8805. PubMed ID: 31015204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of YSA-functionalized and non-functionalized polymeric nanoparticles to injured pulmonary vasculature.
    Patil MA; Upadhyay AK; Hernandez-Lagunas L; Good R; Carpenter TC; Sucharov CC; Nozik-Grayck E; Kompella UB
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1059-S1066. PubMed ID: 30450979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of size and surface ligand of gold nanorods on liver cancer accumulation and photothermal therapy in the second near-infrared window.
    Yang H; He H; Tong Z; Xia H; Mao Z; Gao C
    J Colloid Interface Sci; 2020 Apr; 565():186-196. PubMed ID: 31972332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship analysis of peptides targeting the EphA2 receptor.
    Mitra S; Duggineni S; Koolpe M; Zhu X; Huang Z; Pasquale EB
    Biochemistry; 2010 Aug; 49(31):6687-95. PubMed ID: 20677833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells.
    Liu Z; Tao Z; Zhang Q; Wan S; Zhang F; Zhang Y; Wu G; Wang J
    Cancer Chemother Pharmacol; 2018 Apr; 81(4):687-695. PubMed ID: 29392452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphA2 targeted doxorubicin stealth liposomes as a therapy system for choroidal neovascularization in rats.
    Wang JL; Liu YL; Li Y; Dai WB; Guo ZM; Wang ZH; Zhang Q
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7348-57. PubMed ID: 22977140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High aspect ratio gold nanorods displayed augmented cellular internalization and surface chemistry mediated cytotoxicity.
    DeBrosse MC; Comfort KK; Untener EA; Comfort DA; Hussain SM
    Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):4094-100. PubMed ID: 23910319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.
    Patel K; Doddapaneni R; Sekar V; Chowdhury N; Singh M
    Mol Pharm; 2016 Jun; 13(6):2049-58. PubMed ID: 27070720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable Photothermal Agents based on Gold Nanorods-Encapsulated Microcube.
    Moon HJ; Ku M; Lee H; Yoon N; Yang J; Bong KW
    Sci Rep; 2018 Sep; 8(1):13683. PubMed ID: 30209277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer.
    Van Geer MA; Brevoord D; Kuhlmann KF; Bakker CT; Mizuguchi H; Wesseling JG; Ten Kate FJ; Gouma DJ; Oude Elferink RP; Bosma PJ
    Int J Oncol; 2010 Jan; 36(1):233-44. PubMed ID: 19956852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional gold nanorod theragnostics probed by multi-photon imaging.
    Book Newell B; Wang Y; Irudayaraj J
    Eur J Med Chem; 2012 Feb; 48():330-7. PubMed ID: 22230223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Self-Assembled DNA Origami-Gold Nanorod Complex for Cancer Theranostics.
    Jiang Q; Shi Y; Zhang Q; Li N; Zhan P; Song L; Dai L; Tian J; Du Y; Cheng Z; Ding B
    Small; 2015 Oct; 11(38):5134-41. PubMed ID: 26248642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold nanorods decorated with a cancer drug for multimodal imaging and therapy.
    Nair RV; Santhakumar H; Jayasree RS
    Faraday Discuss; 2018 Apr; 207():423-435. PubMed ID: 29355869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.